optiorx tirzepatide Products prescribed compounded tirzepatide starting at $299/month. OptioRx- Black Friday Intro π
Description
That will change when results of the phase 3 randomized SELECT trial (NCT03574597) are released, perhaps as soon as 2023 or early 2024
Prices vary significantly between compounding pharmacies and vendors
Human causation remains unproven, but the drug is contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2
Song, J
Further data on the risks of diabetic retinopathy associated with incretin therapies will be published from the FOCUS study (semaglutide) and the ANGIOSAFE2 study (semaglutide and tirzepatide)
